Dr Lal Pathlabs Ltd Quarterly Results

Q2 FY26-27 Results Summary

Revenue

The revenue stands at ₹873.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.55 per cent from ₹797.70 crore. This corresponds to a year-on-year *(YoY) growth of 19.61 per cent.

Operating Profit

Operating Profit stands at ₹280.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.17 per cent from ₹247.50 crore. This corresponds to a year-on-year *(YoY) growth of 24.99 per cent.

PBDT

PBDT stands at ₹307.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.56 per cent from ₹273.10 crore. This corresponds to a year-on-year *(YoY) growth of 25.93 per cent.

Profit Before Tax

Profit Before Tax stands at ₹260.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.90 per cent from ₹228.70 crore. This corresponds to a year-on-year *(YoY) growth of 27.95 per cent.

Net Profit

Net Profit stands at ₹193.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.72 per cent from ₹170.50 crore. This represents a 27.40 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Dr Lal Pathlabs Ltd Earnings

CategoryQ2 FY26-27Q2 FY25-26Change %FY25-26FY24-25Change %
Total Revenue873.90730.6019.612,762.902,461.4012.25
Expenses593.80506.5017.242,010.501,765.9013.85
Other Income34.3024.8038.31101.3093.408.46
Operating Profit280.10224.1024.99853.70788.908.21
Depreciation46.9040.5015.80161.80141.9014.02
Interest7.004.8045.8322.8022.302.24
Profit Before Tax260.50203.6027.95669.10624.707.11
Tax66.6051.4029.57159.20172.00-7.44
Net Profit193.90152.2027.40509.80492.203.58
CategoryQ2 FY26-27Q1 FY26-27Change %
Total Revenue873.90797.709.55
Expenses593.80550.207.92
Other Income34.3031.907.52
Operating Profit280.10247.5013.17
Depreciation46.9044.405.63
Interest7.006.3011.11
Profit Before Tax260.50228.7013.90
Tax66.6058.2014.43
Net Profit193.90170.5013.72

Dr Lal Pathlabs Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 2,000Emkay27-Jul-2026
Buy 1,740HDFC Securities31-Dec-2025
Accumulate 2,910HDFC Securities17-Mar-2025

Dr Lal Pathlabs Ltd Financial Reports

Data not available.

Dr Lal Pathlabs Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Dr Lal Pathlabs-0.15%3.74%0.65%1.38%24.98%26.39%
Fortis Health.-6.48%0.91%-1.70%-20.11%-19.06%-24.84%
Narayana Hrudaya-0.31%3.65%10.46%1.08%2.27%5.18%
Global Health-0.01%7.03%7.42%-4.47%14.46%11.07%
Krishna Institu.-1.90%0.02%3.87%-11.10%1.90%-0.94%
Syngene Intl.0.53%0.91%15.58%3.23%-11.27%-32.45%
Dr Agarwal's Hea0.31%0.47%7.03%-5.46%14.46%2.25%

Dr Lal Pathlabs Ltd Corporate Information

Chairman cum Managing Director: Arvind Lal
Whole-time Director: Vandana Lal
Whole Time Director & CEO: Om Prakash Manchanda
Director: Rahul Sharma
Independent Director: Arun Duggal
Independent Director: Anoop Mahendra Singh
Independent Director: Sunil Varma
Independent Director: Harneet Singh Chandhoke
Independent Director: Saurabh Srivastava
Company Secretary: Rajat Kalra

Dr Lal Pathlabs Ltd News

Metropolis Healthcare share hit a 52-week high of ₹574.45, surging 14 per cent in trade. Thyrocare soared 12 per cent to ₹526.10, while Vijaya Diagnostic Centre gained 7 per cent to ₹1,298.45.

Updated On: 08 May 2026 | 3:14 PM IST
More